SAB Biotherapeutics, Inc.
SABSWAs of the close on Aug 24, 2026
Price
—
No recent closing price
Market cap
—
This listing is a preferred share, right, warrant or unit, not the common stock
P/E (diluted TTM)
—
This listing is a preferred share, right, warrant or unit, not the common stock
EPS (TTM)
—
This listing is a preferred share, right, warrant or unit, not the common stock
Dividend yield
—
This listing is a preferred share, right, warrant or unit, not the common stock
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How SAB Biotherapeutics, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Source: SAB Biotherapeutics, Inc. — 10-K filed Mar 9, 2026
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 6 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 26, 2026. The latest institutional report shown is dated Dec 31, 2023; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
No 13F rows are listed for this listing.
- This listing is not SAB Biotherapeutics, Inc.'s common stock, and the 13F data here does not say which of its securities a row holds. A row is listed only when its value per share matches this listing's own latest close, and only when that close is from within about three months of the report date.
- 3 rows left out: their value per share could not be matched to this listing's own price.
Independent insiders buying near the same time
- 2023-11-30–2023-12-07: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2023-11-29–2023-11-30: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2022-09-07–2022-09-13: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2021-10-13–2021-10-14: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2021-10-01–2021-10-01: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2021-01-14–2021-01-14: 3 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2023-12-07 | Sullivan Eddie Joe · Chief Executive Officer | Common Stock | P — Open market or private purchase | +1,740 | 0.88 | SEC filing |
| 2023-11-30 | King Michael · CHIEF FINANCIAL OFFICER | Common Stock | P — Open market or private purchase | +5,000 | 0.90 | SEC filing |
| 2023-11-29 | Reich Samuel J · Executive Chairman | Common Stock | P — Open market or private purchase | +11,000 | 0.89 | SEC filing |
| 2022-09-13 | HAMILTON CHRISTINE E · Director, 10% owner | Common Stock | P — Open market or private purchase | +10,000 | 0.73 | SEC filing |
| 2022-09-07 | Sullivan Eddie Joe · CHIEF EXECUTIVE OFFICER | Common Stock | P — Open market or private purchase | +14,000 | 0.74 | SEC filing |
| 2021-10-26 | Beyer Russell P · Chief Financial Officer | Common Stock | S — Open market or private sale | −278 | 7.90 | SEC filing |
| 2021-10-14 | Reich Samuel J · CEO and CFO | Common Stock | P — Open market or private purchase | +1,000 | 10.11 | SEC filing |
| 2021-10-13 | Katz Ilan · Director, 10% owner | Common Stock | P — Open market or private purchase | +500 | 10.11 | SEC filing |
Showing 8 of 11 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-25 | Kropotova Alexandra · CHIEF MEDICAL OFFICER | Common Stock | F — Payment of exercise price or tax by delivering securities | −988 | SEC filing |
| 2026-03-24 | Kropotova Alexandra · CHIEF MEDICAL OFFICER | Common Stock | F — Payment of exercise price or tax by delivering securities | −988 | SEC filing |
| 2026-02-03 | To Lucy · See Remarks | Stock option (right to buy) | A — Grant, award, or other acquisition | +2,400,000 | SEC filing |
| 2026-02-03 | Reich Samuel J · CEO | Stock option (right to buy) | A — Grant, award, or other acquisition | +4,800,000 | SEC filing |
| 2026-02-03 | Sullivan Eddie Joe · PRESIDENT | Stock option (right to buy) | A — Grant, award, or other acquisition | +3,000,000 | SEC filing |
| 2026-02-03 | Bausch Christoph Lawrence · CHIEF OPERATING OFFICER | Stock option (right to buy) | A — Grant, award, or other acquisition | +1,800,000 | SEC filing |
| 2026-02-03 | Kropotova Alexandra · CHIEF MEDICAL OFFICER | Stock option (right to buy) | A — Grant, award, or other acquisition | +2,400,000 | SEC filing |
| 2026-01-05 | ZACCARDELLI DAVID · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +240,000 | SEC filing |
Showing 8 of 27 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2023-02-28 | Spragens Jeffrey G · Director | Warrants | J — Other acquisition or disposition | +19,936 | SEC filing |
| 2023-02-28 | Reich Samuel J · Executive Chairman | Warrants | J — Other acquisition or disposition | +9,968 | SEC filing |
| 2023-02-28 | Reich Samuel J · Executive Chairman | Warrants | J — Other acquisition or disposition | −208,600 | SEC filing |
| 2022-05-20 | Reich Samuel J · Executive Chairman | Common Stock | J — Other acquisition or disposition | −2,500,127 | SEC filing |
| 2022-05-20 | Reich Samuel J · Executive Chairman | Common Stock | J — Other acquisition or disposition | +207,001 | SEC filing |
| 2022-05-20 | Spragens Jeffrey G · Director | Common Stock | J — Other acquisition or disposition | +299,002 | SEC filing |
Showing 6 of 6 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.